Patent Assignment
Reel/Frame 073977/0840
Change of Name
Recorded: 2026-03-05
Pages: 18
Assignor
MITSUBISHI TANABE PHARMA CORPORATION
Executed: 2025-12-01
Assignee
TANABE PHARMA CORPORATION
3-2-10 DOSHOMACHI, CHUO-KU, OSAKA, JAPAN
Covered Properties
(21)
Glucopyranoside Compound
Substituted Indazole-O-Glucosides
Substituted Fused Heterocyclic C-Glycosides
Substituted Benzimidazole-, Benztriazole-, and Benzimidazolone-O-Glucosides
Crystalline Form of 1-(B-D-Glucopyransoyl)-4-Methyl-3-[5-(4-Fluorophenyl)-2- Thienylmethyl]Benzene Hemihydrate
Crystalline Form of 1-(Beta-D-Glucopyranosyl)-4-Methyl-3-[5-(4-Fluorophenyl)-2-Thienylmethyl]Benzene Hemihydrate
Process for the Preparation of Compounds Useful as Inhibitors of Sglt
Tablets Containing a 1-(¿-D-Glucopyranosyl)-3-(Phenylthienylmethyl)Benzene Compound
Patent:
9,655,852 →
Application:
15/133,889 →
Novel Disubstituted 1, 2, 4-Triazine Compound
Novel Disubstituted 1, 2, 4-Triazine Compound
Patent:
10,329,263 →
Application:
16/016,053 →
Novel Bicyclic or Tricyclic Heterocyclic Compound
Novel Nitrogen-Containing Aromatic Heterocyclic Compound
Novel Bicyclic Heterocyclic Compound
4-Alkoxy-3-(Trifluoromethyl)Benzyl Alcohol Production Method
Method for Producing Triazine Compound
Analysis Method of 3-Methyl-1-Phenyl-2-Pyrazolin-5-One Active Pharmaceutical Ingredient, Treatment for Amyotrophic Lateral Sclerosis, Inhibition of Progression of Amyotrophic Lateral Sclerosis, and Method of Producing Medicament Containing 3-Methyl-1-Phenyl-2-Pyrazolin-5-One Active Pharmaceutical Ingredient
Analysis Method of 3-Methyl-1-Phenyl-2-Pyrazolin-5-One Active Pharmaceutical Ingredient, Treatment for Amyotrophic Lateral Sclerosis, Inhibition of Progression of Amyotrophic Lateral Sclerosis, and Method of Producing Medicament Containing 3-Methyl-1-Phenyl-2-Pyrazolin-5-One Active Pharmaceutical Ingredient
Pharmaceutical Composition
Application:
17/911,329 →
Publication:
US 2023/0115921
Triazine Compound Salt, Crystal Form Thereof, and Production Method Therefor
Application:
18/025,932 →
Publication:
US 2023/0365513
Triazine Compound Salt, Crystal Form Thereof, and Production Method Therefor
Application:
19/329,942 →
Amine Compound and Use Thereof for Medical Purposes
Related Assignments
(19)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 28, 2005
From: NOMURA, SUMIHIRO; KAWANISHI, EIJI; UETA, KIICHIRO
To: TANABE SEIYAKU CO., LTD.
Reel/Frame 016731/0161 →
Assignment of Assignor's Interest
Jun 2, 2006
From: PATEL, MONA; RYBCZYNSKI, PHILIP; URBANSKI, MAUD; ZHANG, XIAOYAN
To: JANSSEN PHARMACEUTICA N.V.
Reel/Frame 017970/0782 →
Assignment of Assignor's Interest
Jun 15, 2006
From: RYBCZYNSKI, PHILIP; URBANSKI, MAUD; ZHANG, XIAOYAN
To: JANSSEN PHARMACEUTICA N.V
Reel/Frame 018004/0201 →
Assignment of Assignor's Interest
Jun 15, 2006
From: URBANSKI, MAUD
To: JANSSEN PHARMACEUTICA N.V.
Reel/Frame 017977/0793 →
Change of Name
Oct 26, 2007
From: TANABE SEIYAKU CO., LTD.
To: MITSUBISHI TANABE PHARMA CORPORATION
Reel/Frame 020021/0001 →
Assignment of Assignor's Interest
Mar 3, 2008
From: NOMURA, SUMIHIRO; KAWANISHI, EIJI
To: MITSUBISHI TANABE PHARMA CORPORATION
Reel/Frame 020588/0269 →
Assignment of Assignor's Interest
Jan 8, 2009
From: ABDEL-MAGID, AHMED F.; CHISHOLM, MAUREEN; MEHRMAN, STEVEN; SCOTT, LORRAINE
To: JANSSEN PHARMACEUTICA N.V.
Reel/Frame 022077/0151 →
Assignment of Assignor's Interest
Jan 8, 2009
From: NOMURA, SUMIHIRO; HONGU, MITSUYA; KOGA, YUICHI
To: MITSUBISHI TANABE PHARMA CORPORATION
Reel/Frame 022077/0623 →
Change of Address
Nov 30, 2015
From: MITSUBISHI TANABE PHARMA CORPORATION
To: MITSUBISHI TANABE PHARMA CORPORATION
Reel/Frame 037163/0890 →
Corrective Assignment to Correct the Address of Assignee Previously Recorded on Reel 037163 Frame 0890. Assignor(S) Hereby Confirms the Correct Address Is as Follows: 3-2-10, Dosho-Machi, Chuo-Ku, Osaka-Shi, Osaka, 541-8505 Japan.
Dec 21, 2015
From: MITSUBISHI TANABE PHARMA CORPORATION
To: MITSUBISHI TANABE PHARMA CORPORATION
Reel/Frame 037354/0934 →
Assignment of Assignor's Interest
Feb 1, 2016
From: OKUYAMA, MASAHIRO; FUKUNAGA, KENJI; USUI, KENJI; HAYASHI, NORIMITSU
To: MITSUBISHI TANABE PHARMA CORPORATION
Reel/Frame 037630/0926 →
Assignment of Assignor's Interest
Oct 21, 2016
From: USHIROGOCHI, HIDEKI; SASAKI, WATARU; ONDA, YUICHI; SAKAKIBARA, RYO
To: MITSUBISHI TANABE PHARMA CORPORATION
Reel/Frame 040085/0983 →
Assignment of Assignor's Interest
Apr 23, 2018
From: OKUYAMA, MASAHIRO; FUKUNAGA, KENJI; USUI, KENJI; HAYASHI, NORIMITSU
To: MITSUBISHI TANABE PHARMA CORPORATION
Reel/Frame 045612/0164 →
Assignment of Assignor's Interest
May 9, 2018
From: SAKAKIBARA, RYO; USHIROGOCHI, HIDEKI; SASAKI, WATARU; ONDA, YUICHI
To: MITSUBISHI TANABE PHARMA CORPORATION
Reel/Frame 045755/0758 →
Assignment of Assignor's Interest
Jan 29, 2019
From: KAWANO, MAKOTO; NAKA, TAKASHI; NAKAMURA, MITSUHARU; TAKAYANAGI, HISAO
To: MITSUBISHI TANABE PHARMA CORPORATION
Reel/Frame 048170/0687 →
Assignment of Assignor's Interest
May 29, 2019
From: YAMAGAMI, TAKAFUMI; YAMASAKI, SOUTA; SETSUTA, TOMOFUMI; SAKAKIBARA, RYO
To: MITSUBISHI TANABE PHARMA CORPORATION
Reel/Frame 049309/0595 →
Assignment of Assignor's Interest
Sep 14, 2022
From: MATSUMOTO, HIDEAKI; YOSHIZAWA, SHOGO; WAKEBAYASHI, DAISUKE
To: MITSUBISHI TANABE PHARMA CORPORATION
Reel/Frame 061095/0449 →
Assignment of Assignor's Interest
Apr 21, 2026
From: TANABE PHARMA CORPORATION
To: SHIONOGI INC.
Reel/Frame 074428/0218 →
Change of Name
Apr 22, 2026
From: MITSUBISHI TANABE PHARMA CORPORATION
To: TANABE PHARMA CORPORATION
Reel/Frame 075454/0787 →